Investegate |SphingoTec GmbH Announcements | SphingoTec GmbH: Endothelial Function Biomarker bio-ADM to Support Risk Stratification and Clinical Management of COVID-19 Patients
Investegate announcements from SphingoTec GmbH, Endothelial Function Biomarker bio-ADM to Support Risk Stratification and Clinical Management of COVID-19 Patients